Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside

REFERENCES

• Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degener-ation: The COMPLETE study. Ophthalmology 2014;121(3):693–701
   PubMed Web of Science ®Google Scholar
• Volz C, Pauly D. Antibody therapies and their challenges in the treatment of age-related macular degeneration. Eur J Pharm Biopharm 2015;95:158–172
   PubMed Web of Science ®Google Scholar
• Auricchio A, Trapani I, Allikmets R. Gene therapy of ABCA4-associated diseases. Cold Spring Harb Perspect Med 2015;5(5):a017301
   PubMed Web of Science ®Google Scholar
• Ma L, Kaufman Y, Zhang J, Washington I. C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease. J Biol Chem 2011;286(10):7966–7974
   PubMed Web of Science ®Google Scholar
• Booij JC, van Soest S, Swagemakers SMA, et al. Functional annotation of the human retinal pigment epithelium transcriptome. BMC Genomics 2009;10:164
   PubMed Web of Science ®Google Scholar
• Sharma RK, Orr WE, Schmitt AD, Johnson DA. A functional profile of gene expression in ARPE-19 cells. BMC Ophthalmol 2005;5:25
   PubMedGoogle Scholar
• Wang X-F, Cui JZ, Nie W, et al. Differential gene expression of early and late passage retinal pigment epithelial cells. Exp Eye Res 2004;79(2):209–221
   PubMed Web of Science ®Google Scholar
• Bressler NM, Bressler SB, Hawkins BS, et al. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number. Am J Ophthalmol 2000;130(4):387–407
   PubMed Web of Science ®Google Scholar
• Algvere P V, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1994;232(12):707–716
   PubMed Web of Science ®Google Scholar
• Algvere PV, Berglin L, Gouras P, et al. Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol 1997;235(3):149–158
   PubMed Web of Science ®Google Scholar
• Peyman GA, Blinder KJ, Paris CL, et al. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg 1991;22(2):102–108
   PubMedGoogle Scholar
• Van Zeeburg EJT, Maaijwee KJM, Missotten TOAR, et al. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: Results up to 7 years. Am J Ophthalmol 2012;153(1):120–127
   PubMed Web of Science ®Google Scholar
• Van Zeeburg EJT, Cereda MG, Amarakoon S, van Meurs JC. Prospective, randomized intervention study comparing retinal pigment epithelium-choroid graft surgery and anti-VEGF Therapy in patients with exudative age-related macular degeneration. Ophthalmologica 2015;233(3–4):134–145
   PubMed Web of Science ®Google Scholar
• Thumann G, Aisenbrey S, Schraermeyer U, et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol (Chicago, Ill 1960) 2000;118(10):1350–1355
   PubMed Web of Science ®Google Scholar
• Aisenbrey S, Lafaut BA, Szurman P, et al. Iris pigment epithelial translocation in the treatment of exudative macular degeneration: A 3-year follow-up. Arch Ophthalmol (Chicago, Ill 1960) 2006;124(2):183–188
   PubMed Web of Science ®Google Scholar
• Bharti K, Rao M, Hull SC, et al. Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci 2014;55(2):1191–1202
   PubMed Web of Science ®Google Scholar
• Desai N, Rambhia P, Gishto A. Human embryonic stem cell cultivation: Historical perspective and evolution of xeno-free culture systems. Reprod Biol Endocrinol 2015;13(1):5
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145–1147
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131(5):861–872
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318(5858):1917–1920
   PubMed Web of Science ®Google Scholar
• Park I-H, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451(7175):141–146
   PubMed Web of Science ®Google Scholar
• Sugita S, Kamao H, Iwasaki Y, et al. Inhibition of T-cell activation by retinal pigment epithelial cells derived from induced pluripotent stem cells. Invest Ophthalmol Vis Sci 2015;56(2):1051–1062
   PubMed Web of Science ®Google Scholar
• Hayashi R, Ishikawa Y, Ito M, et al. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS One 2012;7(9):e45435
   PubMed Web of Science ®Google Scholar
• Klimanskaya I, Hipp J, Rezai KA, et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004;6(3):217–245
   PubMedGoogle Scholar
• Buchholz DE, Hikita ST, Rowland TJ, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009;27(10):2427–2434
   PubMed Web of Science ®Google Scholar
• Buchholz DE, Pennington BO, Croze RH, et al. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med 2013;2(5):384–393
   PubMed Web of Science ®Google Scholar
• Idelson M, Alper R, Obolensky A, et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009;5(4):396–408
   PubMed Web of Science ®Google Scholar
• Zahabi A, Shahbazi E, Ahmadieh H, et al. A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012;21(12):2262–2272
   PubMed Web of Science ®Google Scholar
• Leach LL, Buchholz DE, Nadar VP, et al. Canonical/β-catenin Wnt pathway activation improves retinal pigmented epithelium derivation from human embryonic stem cells. Invest Ophthalmol Vis Sci 2015;56(2):1002–1013
   PubMed Web of Science ®Google Scholar
• Croze RH, Buchholz DE, Radeke MJ, et al. ROCK inhibition extends passage of pluripotent stem cell-derived retinal pigmented epithelium. Stem Cells Transl Med 2014;3(9):1066–1078
   PubMed Web of Science ®Google Scholar
• Tezel TH, Del Priore L V. Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 1997;235(1):41–47
   PubMed Web of Science ®Google Scholar
• Hynes SR, Lavik EB. A tissue-engineered approach towards retinal repair: Scaffolds for cell transplantation to the subretinal space. Graefes Arch Clin Exp Ophthalmol 2010;248(6):763–778
   PubMed Web of Science ®Google Scholar
• Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009;27(9):2126–2135
   PubMed Web of Science ®Google Scholar
• Lund RD, Wang S, Klimanskaya I, et al. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006;8(3):189–199
   PubMedGoogle Scholar
• Carr A-J, Vugler AA, Hikita ST, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009;4(12):e8152
   PubMed Web of Science ®Google Scholar
• Li Y, Tsai Y-T, Hsu C-W, et al. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med 2012;18:1312–1319
   PubMed Web of Science ®Google Scholar
• Schwartz SD, Hubschman J-P, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012;379(9817):713–720
   PubMed Web of Science ®Google Scholar
• Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: Follow-up of two open-label phase 1/2 studies. Lancet 2014;385(9967):509–516
   PubMed Web of Science ®Google Scholar
• Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol (Chicago, Ill 1960) 2005;123(7):935–938
   PubMedGoogle Scholar